Literature DB >> 21676369

High-sensitivity troponin T level and angiographic severity of coronary artery disease.

Gjin Ndrepepa1, Siegmund Braun, Stefanie Schulz, Julinda Mehilli, Albert Schömig, Adnan Kastrati.   

Abstract

The association between circulating levels of cardiac troponins and angiographic severity of coronary artery disease (CAD) has not been studied. We investigated whether there is an association between the level of high-sensitivity troponin T (hs-TnT) and angiographic severity of CAD and whether this association is independent of conventional risk factors, N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and C-reactive protein (CRP). This case-control study included 904 patients with stable CAD (cases) and 412 patients with chest pain but without significant CAD on coronary angiogram (controls). Diagnosis of CAD was confirmed or excluded by coronary angiography. Cardiac TnT was measured with conventional and high-sensitivity assays in parallel using the same plasma sample. In patients with no CAD and in those with 1-, 2-, or 3-vessel disease, hs-TnT levels (median, twenty-fifth to seventy-fifth percentiles) were 0.005 μg/L (<0.003 to 0.009), 0.006 μg/L (0.003 to 0.011), 0.008 μg/L (0.004 to 0.013), and 0.010 μg/L (0.006 to 0.017), respectively (p <0.001). In multivariable analysis adjusting for cardiovascular risk factors and clinical variables including NT-pro-BNP and CRP, hs-TnT was an independent predictor of presence of CAD (adjusted odds ratio 1.30, 95% confidence interval 1.07 to 1.59, p = 0.009). In conclusion, in patients with stable and angiographically proved CAD, hs-TnT level is increased compared to subjects without CAD and correlates with angiographic atherosclerotic extent and burden. The association between increased levels of hs-TnT and presence of CAD was independent of traditional cardiovascular risk factors, NT-pro-BNP, and CRP.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676369     DOI: 10.1016/j.amjcard.2011.04.012

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  High-sensitivity cardiac troponin T level is associated with angiographic complexity of coronary artery disease: a cross-sectional study.

Authors:  Kenji Yamazaki; Raisuke Iijima; Masato Nakamura; Kaoru Sugi
Journal:  Heart Vessels       Date:  2015-05-12       Impact factor: 2.037

Review 2.  Clinical review: Screening for coronary artery disease in type 2 diabetes.

Authors:  Charles T Upchurch; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

3.  Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography.

Authors:  Harald Seifarth; Christopher L Schlett; Sam J Lehman; Fabian Bamberg; Patrick Donnelly; James L Januzzi; Wolfgang Koenig; Quynh A Truong; Udo Hoffmann
Journal:  J Cardiovasc Comput Tomogr       Date:  2014-09-16

4.  Relationships Between Arterial Pressure-Volume Index and Cardiovascular Disease Biomarkers in Patients With Hypertension.

Authors:  Takashi Hitsumoto
Journal:  J Clin Med Res       Date:  2022-06-27

5.  A new generation of biomarkers tests of myocardial necrosis: the real quality a physician can get from the laboratory.

Authors:  Rafał Nikodem Wlazeł; Jarosław Kasprzak; Marek Paradowski
Journal:  Med Sci Monit       Date:  2015-01-28

6.  The ethnicity-specific association of biomarkers with the angiographic severity of coronary artery disease.

Authors:  C M Gijsberts; A Seneviratna; I E M Bank; H M den Ruijter; F W Asselbergs; P Agostoni; J A Remijn; G Pasterkamp; H C Kiat; M Roest; A M Richards; M Y Chan; D P V de Kleijn; I E Hoefer
Journal:  Neth Heart J       Date:  2016-03       Impact factor: 2.380

7.  Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.

Authors:  Cian P McCarthy; Nasrien E Ibrahim; Asya Lyass; Yiwei Li; Hanna K Gaggin; Mandy L Simon; Renata Mukai; Parul Gandhi; Noreen Kelly; Shweta R Motiwala; Roland R J van Kimmenade; Joseph M Massaro; Ralph B D'Agostino; James L Januzzi
Journal:  J Am Heart Assoc       Date:  2018-03-08       Impact factor: 5.501

8.  High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes.

Authors:  Ayman Samman Tahhan; Pratik Sandesara; Salim S Hayek; Muhammad Hammadah; Ayman Alkhoder; Heval M Kelli; Matthew Topel; Wesley T O'Neal; Nima Ghasemzadeh; Yi-An Ko; Mohamad Mazen Gafeer; Naser Abdelhadi; Fahad Choudhary; Keyur Patel; Agim Beshiri; Gillian Murtagh; Jonathan Kim; Peter Wilson; Leslee Shaw; Viola Vaccarino; Stephen E Epstein; Laurence Sperling; Arshed A Quyyumi
Journal:  J Am Heart Assoc       Date:  2018-02-21       Impact factor: 5.501

9.  Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.

Authors:  Muhammad Hammadah; Jeong Hwan Kim; Ayman Samman Tahhan; Bryan Kindya; Chang Liu; Yi-An Ko; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Fahad Choudhary; Mohamad Mazen Gafeer; Naser Abdelhadi; Pratik Pimple; Pratik Sandesara; Bruno B Lima; Amit J Shah; Laura Ward; Michael Kutner; J Douglas Bremner; David S Sheps; Paolo Raggi; Laurence S Sperling; Viola Vaccarino; Arshed A Quyyumi
Journal:  Ann Intern Med       Date:  2018-11-06       Impact factor: 25.391

10.  Severe multivessel coronary artery disease and high-sensitive troponin T.

Authors:  Inga Magdalena Huziuk; Małgorzata Lelonek
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.